Drug Manufacturing and Formulation Program (DMFP)
Award Notice Posted
- Solicitation number
- 75N95024R00077
- Agency
-
National Institute on Drug Abuse
National Institutes of Health, Department of Health and Human Services
- Awarded
- Set-aside
- No set-aside
Opportunity facts
- Contract number
- 75N98026D00014-75N98026F00001
- NAICS code
- 325412 Pharmaceutical Preparation Manufacturing
- Place of performance
- Kansas City, Missouri, United States
- Points of contact
Notice details come from SAM.gov. Updated .
About this opportunity
The National Institute on Drug Abuse, part of the National Institutes of Health under the Department of Health and Human Services, awarded an IDIQ contract to MRIGLOBAL on May 4, 2026, with a maximum ordering value of $49,999,999 for the Drug Manufacturing and Formulation Program.
The IDIQ has a 10-year ordering period running from May 4, 2026 through May 3, 2036. Concurrent with the IDIQ award, the first task order was issued to MRIGLOBAL effective May 4, 2026 through July 3, 2026, in the firm-fixed price amount of $5,000. This was one of four IDIQ contracts awarded under the same solicitation. The award was made under unrestricted competition with no set-aside applied.
Notice text
Four (4) Indefinite Delivery/Indefinite Quantity (IDIQ) type contracts with a maximum ordering value of $49,999,999.00 and an ordering period from May 4, 2026 through May 3, 2036, were awarded on May 4, 2026. Concurrently, the first task orders were issued to each awardee with an effective date of May 4, 2026 through July 3, 2026, in the firm-fixed price amount totaling $5,000.00.
Awarded contract 75N98026D00014 to MRIGLOBAL for 49999999.00 on 2026-05-04.
Notice history
| Notice | Type | Posted |
|---|---|---|
| Drug Manufacturing and Formulation Program (DMFP) | Award Notice | |
| This notice | Award Notice | |
| Drug Manufacturing and Formulation Program (DMFP) | Award Notice | |
| Drug Manufacturing and Formulation Program (DMFP) | Award Notice | |
| Drug Manufacturing and Formulation Program (DMFP) | Solicitation | |
| Drug Manufacturing and Formulation Program (DMFP) | Pre-Solicitation |
Similar open opportunities
| Opportunity | Agency | Set-aside | Responses due |
|---|---|---|---|
| Synthesis and Distribution of Drugs of Abuse and Related Compounds | National Institute on Drug Abuse | No set-aside | |
| Synthesis and Distribution of Drugs of Abuse and Related Compounds | National Institute on Drug Abuse | Total Small Business |
On GovTribe
Work this opportunity
- Track it in your pipeline
- Find teaming partners
- Similar opportunities
- Ask GovTribe AI about this opportunity